Major biomedical research funder Wellcome Trust names Røttingen as its new CEO
LONDON — The Wellcome Trust — the world’s second largest private funder of biomedical research — announced on Wednesday that Norwegian scientist and public health official John-Arne Røttingen has been appointed its new CEO.
Røttingen, currently the ambassador for global health in Norway, will start in January at the London-based charity. He is replacing Jeremy Farrar, who led Wellcome for nearly a decade before becoming the World Health Organization’s chief scientist earlier this year.
